US 11723922
CXCR6-transduced T cells for targeted tumor therapy
granted A61KA61K40/11A61K40/4219
Quick answer
US patent 11723922 (CXCR6-transduced T cells for targeted tumor therapy) held by Ludwig-Maximilians-Universitat Munchen expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ludwig-Maximilians-Universitat Munchen
- Grant date
- Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K40/11, A61K40/4219, A61P, A61P35/00